The reorganization aims to provide dedicated oversight for the company’s dual priorities: rapid market growth and long-term research innovation. Board Chair David Wagner described the change as a maturation of the business, noting that the unified executive model previously in place could no longer sustain the company's current pace of development. By decoupling these functions, the board intends to accelerate the deployment of its proprietary Nuclear Magnetic Resonance imaging solutions.

Couturier, who served as COO for the past two years, plans to build on the commercial momentum achieved through recent market expansions and strengthened intellectual property assets. Meanwhile, Green frames his transition to the CTO role as an opportunity to deepen his focus on the firm’s core engineering and R&D agenda. The company maintains that this shift in personnel is a strategic investment in maintaining its competitive advantage in the industrial imaging sector.